Lodonal (naltrexone low dose oral) / Biostax Corp, Statera BioPharma  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

4 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lodonal (naltrexone low dose oral) / Immune Therap, Statera BioPharma
NCT04674670: Psychobiological Mechanisms Underlying Chronic Pain

Completed
N/A
48
Europe
Bromocriptine Mesylate Capsules, Amisulpride 400 MG, Placebo, Placebo for substudy 2
susanne becker, SNSF
Fibromyalgia, Pain, Chronic, Chronic Pain, Widespread
07/23
07/23
NCT05536050: Study of Low-dose Naltrexone in Chronic Migraine With Fibromyalgia

Recruiting
N/A
30
US
Migraine diary and Questionnaires
Thomas Jefferson University
Chronic Migraine, Fibromyalgia, New Daily Persistent Headache
12/23
12/23
NCT05307627: The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging

Withdrawn
N/A
2500
US
low-dose naltrexone, LDN
AgelessRx
Aging
12/23
12/23
LDN-CRPS, NCT02502162: Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome

Recruiting
N/A
120
US
LDN, Placebo
Stanford University
Complex Regional Pain Syndrome
06/25
06/25

Download Options